Pazopanib for the treatment of soft-tissue sarcoma

Pazopanib is a multikinase inhibitor which potently inhibits the activity of major receptor tyrosine kinases, including vascular endothelial growth factor receptor-1, vascular endothelial growth factor receptor-2, vascular endothelial growth factor receptor-3, platelet-derived growth factor receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Heudel, Pierre, Cassier, Philippe, Derbel, Olfa, Dufresne, Armelle, Meeus, Pierre, Thiesse, Philippe, Ranchère-Vince, Dominique, Blay, Jean Yves, Ray-Coquard, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508654/
https://www.ncbi.nlm.nih.gov/pubmed/23204874
http://dx.doi.org/10.2147/CPAA.S33195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508654/
https://www.ncbi.nlm.nih.gov/pubmed/23204874
http://dx.doi.org/10.2147/CPAA.S33195

Ejemplares similares